ACE Inhibitor‑Induced Cough – A Complete Medical Guide

Overview

ACE (angiotensin‑converting enzyme) inhibitors are a class of medications commonly prescribed for hypertension, heart failure, and diabetic kidney disease. While they are generally well‑tolerated, up to 10–20 % of patients develop a persistent, dry (non‑productive) cough within weeks to months of starting therapy. The cough is thought to result from accumulation of bradykinin and substance P in the respiratory tract, which irritates airway sensory nerves.^[1][2]

Symptoms Checklist

• Dry, tickling cough that is usually non‑productive
• Onset typically 1 week to 6 months after starting an ACE inhibitor
• Worse at night or with lying down
• No fever, chills, or sputum production
• Absence of wheezing or shortness of breath (unless another lung condition co‑exists)
• Improvement after discontinuation of the ACE inhibitor (often within 1–2 weeks)

Risk Factors

• Female sex – women are 2–3 times more likely to develop the cough.^[3]
• Non‑smokers – paradoxically, smokers have a lower reported incidence.
• Asian ethnicity – higher prevalence reported in several studies.
• History of asthma, chronic bronchitis, or other airway hyper‑reactivity.
• Concurrent use of medications that increase bradykinin (e.g., neprilysin inhibitors).

Diagnosis

ACE inhibitor‑induced cough is a diagnosis of exclusion. The typical work‑up includes:

1. Medication review – confirm recent initiation or dose increase of an ACE inhibitor.
2. History & physical exam – rule out infectious, allergic, or cardiac causes.
3. Chest radiograph – to exclude pneumonia, pulmonary edema, or mass lesions.
4. Pulmonary function tests (if indicated) – to differentiate from asthma or COPD.
5. Trial discontinuation – stopping the ACE inhibitor (or switching to an ARB) and observing for cough resolution is often the definitive test.

Laboratory tests (CBC, CRP) are usually normal unless another process is present.

Treatment Options

Management focuses on eliminating the offending agent and providing symptomatic relief.

Medication‑Based Strategies

• Switch to an angiotensin II receptor blocker (ARB) – ARBs (e.g., losartan, valsartan) have a <1 % incidence of cough and provide similar cardiovascular benefits.^[4]
• Temporary use of a low‑dose cough suppressant (e.g., dextromethorphan) while transitioning medications.
• In rare, refractory cases, adding a low‑dose inhaled corticosteroid may reduce airway irritation, but evidence is limited.

Home & Lifestyle Measures

• Stay well‑hydrated – thin mucus secretions.
• Use a humidifier to keep airway mucosa moist.
• Honey‑lemon tea (for adults) can soothe throat irritation.
• Avoid irritants such as tobacco smoke, strong fragrances, and cold, dry air.

Prevention

• Discuss cough risk with your provider before starting an ACE inhibitor, especially if you have known risk factors.
• Consider starting with an ARB if you have a strong personal or family history of drug‑induced cough.
• Monitor for cough within the first 3 months of therapy; early reporting can lead to prompt medication adjustment.

Living With ACE Inhibitor‑Induced Cough

Even after switching medications, some patients experience a lingering cough for several weeks. The following tips can help:

• Track symptoms in a diary – note timing, severity, and triggers.
• Practice controlled breathing techniques (e.g., pursed‑lip breathing) to reduce cough reflex sensitivity.
• Engage in regular moderate exercise (as tolerated) to improve overall lung capacity.
• Maintain routine follow‑up appointments to ensure blood pressure and heart‑failure goals remain met after medication change.

When to Seek Emergency Care

Although the cough itself is rarely life‑threatening, certain associated symptoms warrant immediate medical attention:

• Sudden shortness of breath or difficulty breathing.
• Chest pain that radiates to the arm, jaw, or back.
• Cough producing blood (hemoptysis).
• High fever (>38 °C / 100.4 °F) with chills.
• Swelling of the lips, tongue, or throat (possible allergic reaction to a medication change).

Medical Disclaimer: This guide is for informational purposes only and does not replace professional medical advice, diagnosis, or treatment. Always consult a qualified health‑care provider regarding any medical condition or medication changes.

References

1. Mayo Clinic. “ACE inhibitors and cough.” Mayoclinic.org. Accessed Jan 2026.
2. National Institutes of Health (NIH). “Mechanisms of ACE inhibitor–induced cough.” NCBI. 2022.
3. Cleveland Clinic. “Why do ACE inhibitors cause cough?” clevelandclinic.org. Updated 2023.
4. Johns Hopkins Medicine. “Angiotensin II receptor blockers (ARBs) as alternatives to ACE inhibitors.” hopkinsmedicine.org. 2024.
5. CDC. “Hypertension treatment guidelines.” cdc.gov. 2023.